Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
Background: Protein biomarkers with associations with the activity and outcomes of diseases are being identified by modern proteomic technologies. They may be simple, accessible, cheap and safe tests that can inform diagnosis, prognosis, treatment selection, monitoring of disease activity and therap...
Similar Items
-
Renal cancer biomarkers: the promise of personalized care
by: Vasudev Naveen S, et al.
Published: (2012-09-01) -
Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease
by: Samantha C. Loane, et al.
Published: (2022-09-01) -
SCUBE1: a promising biomarker in renal cell cancer
by: Ersagun Karagüzel, et al. -
Сurrent state of clinical significance of early kidney injury markers
by: D. N. Khotko, et al.
Published: (2022-06-01) -
The Value of Biomarkers in Major Cardiovascular Surgery Necessitating Cardiopulmonary Bypass
by: Adrian Stef, et al.
Published: (2024-09-01)